Clinical Trial Update: Methimazole to Treat Polymyositis and Dermatomyositis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating methimazole for treatment of inflammatory myopathies (dermatomyositis and polymyositis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Polymyositis

Drugs mentioned

• Methimazole (Methimazole)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Dermatomyositis, Polymyositis | Phase 2 | Status: COMPLETED